Royalty Pharma PLC at JPMorgan Healthcare Conference (Virtual) Transcript
Good morning. I'm Chris Schott at JPMorgan, and very pleased to be introducing Royalty Pharma today in their first presentation as a public company at the JPMorgan Conference. From the company, we have Pablo Legorreta, the company's founder and CEO. He's going to make some opening remarks about this very unique business, and we'll bring a broader swath of the management team on board for the Q&A.
Also as a reminder, after the presentation, we will have a Q&A session. Anyone who wants to ask a question, please submit those through the Ask a Question button on the screen, and I'll make sure I integrate those into the questions as we go through.
So with that, let me turn the presentation over to Pablo.
Thank you, Chris, and good morning, everyone. I have been attending the JPMorgan Healthcare Conference for 24 straight years uninterrupted as an investor from its early days
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |